Sabin Nsanzimana Selected Research

Opportunistic Infections (Opportunistic Infection)

1/2021

Predictors of Rifampicin-Resistant Tuberculosis Mortality among HIV-Coinfected Patients in Rwanda.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabin Nsanzimana Research Topics

Disease

7	Infections 01/2022 - 01/2017
5	Chronic Hepatitis C 01/2022 - 01/2019
5	HIV Infections (HIV Infection) 11/2018 - 01/2015
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
3	Hepatitis C 06/2020 - 01/2017
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 10/2015
2	COVID-19 01/2022 - 01/2021
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2017 - 11/2016
1	Febrile Seizures (Febrile Seizure) 07/2022
1	Gastroenteritis 07/2022
1	Fever (Fevers) 07/2022
1	Hyperglycemia 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Noncommunicable Diseases 01/2021
1	Heart Failure 01/2021
1	Rubella (German Measles) 01/2016
1	Measles 01/2016
1	Communicable Diseases (Infectious Diseases) 10/2015
1	Syphilis 02/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015

Drug/Important Bio-Agent (IBA)

6	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
3	VaccinesIBA 07/2022 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2017 - 01/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2022
1	Monoclonal AntibodiesIBA 01/2022
1	favipiravirIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2022
1	SofosbuvirIBA 01/2022
1	velpatasvirIBA 01/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2021
1	sofosbuvir drug combination ledipasvirIBA 01/2019
1	Viral RNAIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	HIV AntibodiesIBA 11/2015
1	ReaginsIBA 02/2015
1	SolutionsIBA 01/2015
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2015

Therapy/Procedure

5	Therapeutics 01/2022 - 11/2016
2	Condoms (Condom) 10/2017 - 11/2016
1	Ambulatory Care (Outpatient Care) 01/2021
1	Chemoprevention 10/2015
1	Art Therapy 01/2015